Matthias Ocker

Matthias Ocker has a diverse and extensive work experience in the field of medicine and research. Matthias is currently the Head of Experimental Medicine at Tacalyx GmbH, a role they assumed in March 2023. Prior to this, they founded and served as the CEO of EO Translational Insights Consulting GmbH in February 2023.

From 2016 until their recent career advancements, Matthias held a position as a Professor at Charité. Before that, they worked at Anji Pharma as the Vice President of Translational Medicine from May 2022 to February 2023.

Matthias also has a significant background in the pharmaceutical industry. Matthias held various roles at Bayer from 2012 to 2020, including Senior Clinical Development Leader, Early Clinical Leader, Head of Biomarker Oncology, and Director Expert Experimental Medicine Oncology.

Prior to joining the industry, Matthias was a Professor of Medicine and Director of Research Institute at the University of Marburg from 2009 to 2012. Matthias also served as the Head of Medical Research at Friedrich-Alexander-University Erlangen-Nurnberg from 2004 to 2009, and as a Scientific Associate and Post-Doctoral Fellow from 2000 to 2004.

Overall, Matthias Ocker has established a successful career in medicine and research, with a focus on experimental medicine and translational insights.

Matthias Ocker's education history begins with their attendance at the Schiller-Gymnasium Hof from 1986 to 1993. However, no specific degree or field of study is mentioned for this period.

Following that, Ocker pursued their medical studies at FAU Erlangen-Nürnberg from 1993 to 1999, earning a Staatsexamen in Medicine.

Continuing their education, they then obtained a degree of 'Dr. med.' from FAU Erlangen-Nürnberg in the year 2000, after completing their promotion.

Lastly, in 2005, Ocker attended FAU Erlangen-Nürnberg once again for the field of Experimental Medicine, completing a Habilitation degree.